Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-14

FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approves a supplemental application for the dorzolamide hydrochloride and timolol maleate combination eye drop, a generic product used to reduce intraocular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide Hydrochloride and Timolol Maleate (Dorzolamide hydrochloride and timolol maleate)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)